Filed May 5, the individual and class-action complaint alleges breach of contract and breach of the implied covenant of good faith and fair dealing.
Blue Shield treats Coflex as an “investigational” procedure, which is why it is not eligible for coverage, according to the complaint.
However, the lawsuit claims that Coflex does not fit into any of Blue Shield’s “medical policies” on investigational procedures and should be eligible for coverage.
Paradigm Spine won FDA approval for Coflex in 2012.
The lawsuit is seeking declaratory and injunctive relief, as well as money damages against Blue Shield.
More articles on spine:
28.4M elective surgeries could be canceled in 2020 — orthopedic procedures hit hardest
Research finds lowest average cost of hip, knee replacements at 3 New York City hospitals
Texas orthopedic group snares 2 paycheck protection program loans
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
